Announcements Trials
Browse Landscape

Phase

Phase 2 73Phase 3 29Phase 1 26Phase 1/2 13Phase 2/3 4Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Not yet recruiting 2Completed 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Standard of Care 40Methods 37Exercise 36Educational Status 36Practice Guidelines as Topic 35Surveys and Questionnaires 33Early Intervention, Educational 32Radiotherapy 25Radiosurgery 25Magnetic Resonance Spectroscopy 23Interviews as Topic 21Blood Specimen Collection 17Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 12Palliative Care 12Counseling 12Radiation 11Nutrition Assessment 11Specimen Handling 10Resistance Training 10Proton Therapy 8Mammography 8Biopsy 8Radiofrequency Ablation 7Exercise Test 7Drug Therapy 7Diet Therapy 7Control Groups 7Yoga 6X-Rays 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × atezolizumab × Clear all
NCT04180072 2026-04-09

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

National Health Research Institutes, Taiwan

Phase NA Active not recruiting
51 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡